{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:52:40Z","timestamp":1787759560161,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18dm0307003h0001"],"award-info":[{"award-number":["18dm0307003h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24wm0625001h"],"award-info":[{"award-number":["24wm0625001h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s12149-026-02158-4","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T05:45:55Z","timestamp":1769147155000},"page":"575-583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Regional distribution of an amyloid radiotracer in healthy aged human brain measured by PET with [18F]flutemetamol: a relation with myelin distribution"],"prefix":"10.1007","volume":"40","author":[{"given":"Hiroshi","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Yamakuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harumasa","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsunari","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobukatsu","family":"Sawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hanakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"2158_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"2158_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256:184\u20135.","journal-title":"Science"},{"key":"2158_CR3","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1021\/jm030026b","volume":"46","author":"CA Mathis","year":"2003","unstructured":"Mathis CA, Wang Y, Holt DP, Huang GF, Debnath ML, Klunk WE. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem. 2003;46:2740\u201354.","journal-title":"J Med Chem"},{"key":"2158_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306\u201319.","journal-title":"Ann Neurol"},{"key":"2158_CR5","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2967\/jnumed.109.063305","volume":"50","author":"N Nelissen","year":"2009","unstructured":"Nelissen N, Van Laere K, Thurfjell L, Owenius R, Vandenbulcke M, Koole M, et al. Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease. J Nucl Med. 2009;50:1251\u20139.","journal-title":"J Nucl Med"},{"key":"2158_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ana.22068","volume":"68","author":"R Vandenberghe","year":"2010","unstructured":"Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, et al. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol. 2010;68:319\u201329.","journal-title":"Ann Neurol"},{"key":"2158_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.nicl.2015.10.007","volume":"9","author":"JM Mountz","year":"2015","unstructured":"Mountz JM, Laymon CM, Cohen AD, Zhang Z, Price JC, Boudhar S, et al. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer\u2019s subjects. Neuroimage Clin. 2015;9:592\u20138.","journal-title":"Neuroimage Clin"},{"key":"2158_CR8","doi-asserted-by":"publisher","first-page":"578753","DOI":"10.3389\/fneur.2020.578753","volume":"11","author":"H Matsuda","year":"2020","unstructured":"Matsuda H, Ito K, Ishii K, Shimosegawa E, Okazawa H, Mishina M, et al. Quantitative evaluation of 18F-flutemetamol PET in patients with cognitive impairment and suspected Alzheimer\u2019s disease: a multicenter study. Front Neurol. 2020;11:578753.","journal-title":"Front Neurol"},{"key":"2158_CR9","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1523\/JNEUROSCI.23-06-02086.2003","volume":"23","author":"WE Klunk","year":"2003","unstructured":"Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Shao L, et al. The binding of 2-(4\u2019-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci. 2003;23:2086\u201392.","journal-title":"J Neurosci"},{"key":"2158_CR10","doi-asserted-by":"publisher","first-page":"10598","DOI":"10.1523\/JNEUROSCI.2990-05.2005","volume":"25","author":"WE Klunk","year":"2005","unstructured":"Klunk WE, Lopresti BJ, Ikonomovic MD, Lefterov IM, Koldamova RP, Abrahamson EE, et al. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer\u2019s disease brain but not in transgenic mouse brain. J Neurosci. 2005;25:10598\u2013606.","journal-title":"J Neurosci"},{"key":"2158_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2967\/jnumed.108.057984","volume":"50","author":"MT Fodero-Tavoletti","year":"2009","unstructured":"Fodero-Tavoletti MT, Rowe CC, McLean CA, Leone L, Li QX, Masters CL, et al. Characterization of PiB binding to white matter in Alzheimer disease and other dementias. J Nucl Med. 2009;50:198\u2013204.","journal-title":"J Nucl Med"},{"key":"2158_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12883-015-0502-2","volume":"15","author":"JA Mat\u00edas-Guiu","year":"2015","unstructured":"Mat\u00edas-Guiu JA, Cabrera-Mart\u00edn MN, Mat\u00edas-Guiu J, Oreja-Guevara C, Riola-Parada C, Moreno-Ramos T, et al. Amyloid PET imaging in multiple sclerosis: an 18F-florbetaben study. BMC Neurol. 2015;15:243.","journal-title":"BMC Neurol"},{"key":"2158_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fneur.2016.00053","volume":"7","author":"JA Mat\u00edas-Guiu","year":"2016","unstructured":"Mat\u00edas-Guiu JA, Oreja-Guevara C, Cabrera-Mart\u00edn MN, Moreno-Ramos T, Carreras JL, Mat\u00edas-Guiu J. Amyloid proteins and their role in multiple sclerosis. Considerations in the use of amyloid-PET imaging. Front Neurol. 2016;7:53.","journal-title":"Front Neurol"},{"key":"2158_CR14","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1177\/1352458506070928","volume":"12","author":"C Laule","year":"2006","unstructured":"Laule C, Leung E, Lis DK, Traboulsee AL, Paty DW, MacKay AL, et al. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Mult Scler. 2006;12:747\u201353.","journal-title":"Mult Scler"},{"key":"2158_CR15","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/brain\/awac436","volume":"146","author":"CWJ van der Weijden","year":"2023","unstructured":"van der Weijden CWJ, Biondetti E, Gutmann IW, Dijkstra H, McKerchar R, de Paula FD, et al. Quantitative myelin imaging with MRI and PET: an overview of techniques and their validation status. Brain. 2023;146:1243\u201366.","journal-title":"Brain"},{"key":"2158_CR16","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/jon.12657","volume":"29","author":"H Liu","year":"2019","unstructured":"Liu H, Rubino C, Dvorak AV, Jarrett M, Ljungberg E, Vavasour IM, et al. Myelin water atlas: a template for myelin distribution in the brain. J Neuroimaging. 2019;29:699\u2013706.","journal-title":"J Neuroimaging"},{"key":"2158_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41598-020-79540-3","volume":"11","author":"AV Dvorak","year":"2021","unstructured":"Dvorak AV, Swift-LaPointe T, Vavasour IM, Lee LE, Abel S, Russell-Schulz B, et al. An atlas for human brain myelin content throughout the adult life span. Sci Rep. 2021;11:269.","journal-title":"Sci Rep"},{"key":"2158_CR18","first-page":"e70048","volume":"17","author":"K Yoshinaga","year":"2025","unstructured":"Yoshinaga K, Matsushima T, Abe M, Takamura T, Togo H, Wakasugi N, et al. Age-disproportionate atrophy in Alzheimer\u2019s disease and Parkinson\u2019s disease spectra. Alzheimers Dement Diagn Assess Dis Monit. 2025;17:e70048.","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"key":"2158_CR19","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43:2412\u20134.","journal-title":"Neurology"},{"key":"2158_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/978-94-015-8749-5_18","volume-title":"Three-dimensional image reconstruction in radiology and nuclear medicine","author":"CC Watson","year":"1996","unstructured":"Watson CC, Newport D, Casey ME. A single scatter simulation technique for scatter correction in 3D PET. In: Grangeat P, Amans JL, editors. Three-dimensional image reconstruction in radiology and nuclear medicine. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1996. p. 255\u201368."},{"key":"2158_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000104478","volume":"24","author":"Y Shinohara","year":"2007","unstructured":"Shinohara Y, Tohgi H, Hirai S, Terashi A, Fukuuchi Y, Yamaguchi T, et al. Effect of the Ca antagonist nilvadipine on stroke occurrence or recurrence and extension of asymptomatic cerebral infarction in hypertensive patients with or without history of stroke (PICA study). 1. Design and results at enrollment. Cerebrovasc Dis. 2007;24:202\u20139.","journal-title":"Cerebrovasc Dis"},{"key":"2158_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am J Roentgenol. 1987;149:351\u20136.","journal-title":"AJR Am J Roentgenol"},{"key":"2158_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/jcbfm.1990.88","volume":"10","author":"KJ Friston","year":"1990","unstructured":"Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS. The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab. 1990;10:458\u201366.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2158_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","volume":"38","author":"J Ashburner","year":"2007","unstructured":"Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 2007;38:95\u2013113.","journal-title":"Neuroimage"},{"key":"2158_CR25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1006\/nimg.2000.0582","volume":"11","author":"J Ashburner","year":"2000","unstructured":"Ashburner J, Friston KJ. Voxel-based morphometry--the methods. Neuroimage. 2000;11:805\u201321.","journal-title":"Neuroimage"},{"key":"2158_CR26","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.neuroimage.2005.02.018","volume":"26","author":"J Ashburner","year":"2005","unstructured":"Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005;26:839\u201351.","journal-title":"Neuroimage"},{"key":"2158_CR27","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","volume":"25","author":"JC Price","year":"2005","unstructured":"Price JC, Klunk WE, Lopresti BJ, Lu X, Hoge JA, Ziolko SK, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab. 2005;25:1528\u201347.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2158_CR28","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2967\/jnumed.106.037556","volume":"48","author":"Y Kudo","year":"2007","unstructured":"Kudo Y, Okamura N, Furumoto S, Tashiro M, Furukawa K, Maruyama M, et al. 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer\u2019s disease patients. J Nucl Med. 2007;48:553\u201361.","journal-title":"J Nucl Med"},{"key":"2158_CR29","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2967\/jnumed.114.142109","volume":"55","author":"L Thurfjell","year":"2014","unstructured":"Thurfjell L, Lilja J, Lundqvist R, Buckley C, Smith A, Vandenberghe R, et al. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads. J Nucl Med. 2014;55:1623\u20138.","journal-title":"J Nucl Med"},{"key":"2158_CR30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00429-022-02600-z","volume":"228","author":"S Sandrone","year":"2023","unstructured":"Sandrone S, Aiello M, Cavaliere C, de Thiebaut Schotten M, Reimann K, Troakes C, et al. Mapping myelin in white matter with T1-weighted\/T2-weighted maps: discrepancy with histology and other myelin MRI measures. Brain Struct Funct. 2023;228:525\u201335.","journal-title":"Brain Struct Funct"},{"key":"2158_CR31","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/ana.22320","volume":"69","author":"B Stankoff","year":"2011","unstructured":"Stankoff B, Freeman L, Aigrot MS, Chardain A, Dolle F, Williams A, et al. Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-11C]-2-(4\u2019-methylaminophenyl)- 6-hydroxybenzothiazole. Ann Neurol. 2011;69:673\u201380.","journal-title":"Ann Neurol"},{"key":"2158_CR32","doi-asserted-by":"publisher","first-page":"932","DOI":"10.2967\/jnumed.113.133793","volume":"55","author":"H Ito","year":"2014","unstructured":"Ito H, Shimada H, Shinotoh H, Takano H, Sasaki T, Nogami T, et al. Quantitative analysis of amyloid deposition in Alzheimer disease using PET and the radiotracer 11C-AZD2184. J Nucl Med. 2014;55:932\u20138.","journal-title":"J Nucl Med"},{"key":"2158_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neurobiolaging.2021.06.002","volume":"106","author":"EJ Canales-Rodr\u00edguez","year":"2021","unstructured":"Canales-Rodr\u00edguez EJ, Alonso-Lana S, Verdolini N, Sarr\u00f3 S, Feria I, Montoro I, et al. Age- and gender-related differences in brain tissue microstructure revealed by multi-component T2 relaxometry. Neurobiol Aging. 2021;106:68\u201379.","journal-title":"Neurobiol Aging"},{"key":"2158_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/cne.1205","volume":"435","author":"A Peters","year":"2001","unstructured":"Peters A, Sethares C, Killiany RJ. Effects of age on the thickness of myelin sheaths in monkey primary visual cortex. J Comp Neurol. 2001;435:241\u20138.","journal-title":"J Comp Neurol"},{"key":"2158_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/neuro.05.011.2009","volume":"3","author":"A Peters","year":"2009","unstructured":"Peters A. The effects of normal aging on myelinated nerve fibers in monkey central nervous system. Front Neuroanat. 2009;3:11.","journal-title":"Front Neuroanat"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02158-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02158-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02158-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:39:01Z","timestamp":1777387141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-026-02158-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2158"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02158-4","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}